USD 2.33
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 142.19 Million USD | 15.79% |
2022 | 122.8 Million USD | 66.77% |
2021 | 73.63 Million USD | 23643.29% |
2020 | 310.13 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 126.15 Million USD | -11.29% |
2024 Q2 | 117.13 Million USD | -7.15% |
2023 Q3 | 173.44 Million USD | 6.74% |
2023 FY | 142.19 Million USD | 15.79% |
2023 Q4 | 142.19 Million USD | -18.01% |
2023 Q2 | 162.49 Million USD | 10.73% |
2023 Q1 | 146.74 Million USD | 19.49% |
2022 Q1 | 49.8 Million USD | -21.17% |
2022 FY | 122.8 Million USD | 66.77% |
2022 Q4 | 122.8 Million USD | 237.57% |
2022 Q3 | 36.37 Million USD | -10.99% |
2022 Q2 | 40.86 Million USD | -17.94% |
2021 Q3 | 65.9 Million USD | -22.8% |
2021 Q2 | 85.36 Million USD | 15.59% |
2021 Q4 | 63.17 Million USD | -4.14% |
2021 FY | 73.63 Million USD | 23643.29% |
2021 Q1 | 73.85 Million USD | 0.0% |
2020 FY | 310.13 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Abbott Laboratories | 34.38 Billion USD | 99.586% |
Artivion, Inc. | 510.61 Million USD | 72.152% |
Avanos Medical, Inc. | 456.1 Million USD | 68.823% |
Butterfly Network, Inc. | 84.22 Million USD | -68.84% |
Butterfly Network, Inc. | 84.22 Million USD | -68.84% |
Bio-Rad Laboratories, Inc. | 3.55 Billion USD | 96.003% |
Boston Scientific Corporation | 15.6 Billion USD | 99.089% |
CONMED Corporation | 1.46 Billion USD | 90.299% |
Edwards Lifesciences Corporation | 2.64 Billion USD | 94.621% |
Paragon 28, Inc. | 162.95 Million USD | 12.739% |
Glaukos Corporation | 478.64 Million USD | 70.292% |
Globus Medical, Inc. | 1.08 Billion USD | 86.932% |
Inspire Medical Systems, Inc. | 104.29 Million USD | -36.34% |
Integer Holdings Corporation | 1.41 Billion USD | 89.938% |
Medtronic plc | 39.56 Billion USD | 99.641% |
Myomo, Inc. | 5.59 Million USD | -2442.801% |
Nevro Corp. | 330.31 Million USD | 56.95% |
Owlet, Inc. | 73.79 Million USD | -92.684% |
Penumbra, Inc. | 377.36 Million USD | 62.318% |
Vicarious Surgical Inc. | 21.89 Million USD | -549.459% |
Smith & Nephew plc | 4.77 Billion USD | 97.019% |
STERIS plc | 4.74 Billion USD | 97.005% |
Stryker Corporation | 21.31 Billion USD | 99.333% |
Vapotherm, Inc. | 132.95 Million USD | -6.956% |
Zimmer Biomet Holdings, Inc. | 9 Billion USD | 98.422% |